Efficacy and safety of elobixibat before dinner administration in patients with functional constipatio
Not Applicable
Completed
- Conditions
- functional constipation
- Registration Number
- JPRN-UMIN000036163
- Lead Sponsor
- ODAKA CLINIC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 41
Inclusion Criteria
Not provided
Exclusion Criteria
1 Patients who were suspected of organic constipation 2 Patients who were taking constipation related medicines* within 2 weeks before elobixibat administration 3 Patients with medication history for psychotropics, antidepressants and/or anxiolytics *Constipation related medicines Laxatives (Magnesium oxide preparation, sodium picosulfate, sennoside, etc.) Chinese herbal medicines having indication of constipation (Daio-kanzo-to, Choi-joki-to, Dai-saiko-to, etc.) Therapeutic medicines of irritable bowel syndrome (Ramosetron hydrochloride, calcium polycarbophil, trimebutine maleate etc.) Prokinetics (Mosapride citrate, metoclopramide, domperidone, etc.)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method